Share the post "Sasken Technologies Limited Shareholding Update: An Examination of Financial Performance for FY (Q4-Mar 2023-2024)"
Sasken Technologies Limited has released its latest shareholding reports, covering the quarter and the first half of the fiscal year ending on (Q4-Mar 2023-2024).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
| Shareholder Name | Previous Quater Quantity(In Crores) | Current Quater Quantity(In Crores) | Previous Quater Shares(in %) | Current Quater Shares(in %) | Quater to Quater Difference |
|---|---|---|---|---|---|
| Promoters | 0.65 | 0.65 | 43.44 | 43.25 | -0.19 % |
| Public | 0.85 | 0.86 | 36.9 | 37.22 | +0.32 % |
| DII | 0.02 | 0.02 | 1.09 | 1.1 | +0.01 % |
| FII | 0.28 | 0.28 | 18.52 | 18.38 | -0.14 % |
| Government | 0.00 | 0.00 | 0.05 | 0.05 | 0 |
Promoters’ shareholding decreased from 43.44% in December 2023 to 43.25% in March 2024. This reduction indicates that the promoters’ control over Company has weakened during this period.The percentage of shares held by the public increased from 36.9% in December 2023 to 37.22% in March 2024.This change suggests that the public’s investment in the company grew during the quarter.DIIs (Domestic Institutional Investors) shareholding increased from 1.09% in December 2023 to 1.1% in March 2024 , indicating that domestic institutions increased their stake in the company by 0.01% . FIIs (Foreign Institutional Investors) shareholding decreased from 18.52% in December 2023 to 18.38% in March 2024 ,indicating that foreign institutions reduced their investments by 1.5% in the company during the quarter. This suggests a pullback in their investment .During quater from December 2023 to March 2024, Goverenment ownership remained steady at 0.05%.This indicates that the government’s stake in the company remained consistent during this period.
Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
| Shareholder Name | Previous Quarter Quantity (In crores) | Current Quarter Quantity (In crores) | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
|---|---|---|---|---|---|
| PRANABH DINESH MODY | 0.029 | 0.029 | 1.92 | 1.91 | -0.01 % |
| BHARAT PRAVINCHANDRA MEHTA | 0.000 | 0.000 | 0.02 | 0.01 | -0.01 % |
| NAMRATA KUSHAL DALAL | 0.000 | 0.000 | 0.01 | 0 | -0.01 % |
| SHIRISH BHAGWANLAL MODY | 0.000 | 0.000 | 0.01 | 0 | -0.01 % |
| BHARATI SHIRISH MODY | 0.001 | 0.000 | 0.05 | 0 | -0.05 % |
| LEKAR PHARMA LIMITED | 0.064 | 0.064 | 4.27 | 4.26 | -0.01 % |
| ERAGON VENTURES LIMITED (FORMERLY KNOWN AS IFIUNIK PHARMACEUTICALS LIMITED) | 0 | 0.010 | 0 | 0.68 | +0.68% |
| J B MODY ENTERPRISES LLP | 0.001 | 0.001 | 0.09 | 0.06 | -0.03 % |
| RAJIV C MODY | 0.156 | 0.156 | 10.34 | 10.32 | -0.02 % |
| NAMAN R MODY | 0.094 | 0.094 | 6.25 | 6.24 | -0.01 % |
| SAKHEE R MODY | 0.040 | 0.040 | 2.64 | 2.63 | -0.01 % |
| BIPIN AMRITLAL TURAKHIA | 0.038 | 0.038 | 2.52 | 2.51 | -0.01 % |
| ERAGON VENTURES LIMITED (FORMERLY KNOWN AS IFIUNIK PHARMACEUTICALS LIMITED) | 0.010 | 0 | 0.69 | 0 | -0.69% |
PRANABH DINESH MODY faced a downturn in stakeholding this quarter, witnessing a decline of -0.01 % in stakeholding compared to the previous quarter.BHARAT PRAVINCHANDRA MEHTA faced a downturn in stakeholding this quarter, witnessing a decline of -0.01 % in stakeholding compared to the previous quarter.NAMRATA KUSHAL DALAL faced a downturn in stakeholding this quarter, witnessing a decline of -0.01 % in stakeholding compared to the previous quarter.SHIRISH BHAGWANLAL MODY faced a downturn in stakeholding this quarter, witnessing a decline of -0.01 % in stakeholding compared to the previous quarter.BHARATI SHIRISH MODY faced a downturn in stakeholding this quarter, witnessing a decline of -0.05 % in stakeholding compared to the previous quarter.LEKAR PHARMA LIMITED faced a downturn in stakeholding this quarter, witnessing a decline of -0.01 % in stakeholding compared to the previous quarter.J B MODY ENTERPRISES LLP faced a downturn in stakeholding this quarter, witnessing a decline of -0.03 % in stakeholding compared to the previous quarter.RAJIV C MODY faced a downturn in stakeholding this quarter, witnessing a decline of -0.02 % in stakeholding compared to the previous quarter.NAMAN R MODY faced a downturn in stakeholding this quarter, witnessing a decline of -0.01 % in stakeholding compared to the previous quarter.SAKHEE R MODY faced a downturn in stakeholding this quarter, witnessing a decline of -0.01 % in stakeholding compared to the previous quarter.BIPIN AMRITLAL TURAKHIA faced a downturn in stakeholding this quarter, witnessing a decline of -0.01 % in stakeholding compared to the previous quarter.ERAGON VENTURES LIMITED (FORMERLY KNOWN AS IFIUNIK PHARMACEUTICALS LIMITED) had no shares in the previous quarter but now holds 0.68% of shares in the current quarter.ERAGON VENTURES LIMITED (FORMERLY KNOWN AS IFIUNIK PHARMACEUTICALS LIMITED) had 0.69% of shares in the previous quarter but exited in the current quarter.
| Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
|---|---|---|---|---|---|
| Key Managerial Personnel | 0.000 | 0.000 | 0 | 0.03 | + 0.03 % |
| Investor Education and Protection Fund | 0.003 | 0.003 | 0.19 | 0.2 | + 0.01 % |
| Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 0.299 | 0.299 | 19.85 | 19.81 | -0.04 % |
| Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 0.126 | 0.130 | 8.37 | 8.6 | + 0.23 % |
| MADHUKER JAYANTILAL JHAVERI | 0.051 | 0.051 | 3.41 | 3.4 | -0.01 % |
| Non Resident Indians (NRIs) | 0.063 | 0.062 | 4.19 | 4.13 | -0.06 % |
| Bodies Corporate | 0.035 | 0.036 | 2.36 | 2.42 | + 0.06 % |
| Any Other (specify) | 0.014 | 0.016 | 0.96 | 1.07 | + 0.11 % |
| Trusts | 0.000 | 0.000 | 0 | 0.01 | + 0.01 % |
| HUF | 0.013 | 0.014 | 0.84 | 0.94 | + 0.1 % |
Leading the way to higher stakeholding, Key Managerial Personnel has significantly boosted stakeholding by an impressive 0.03 %.Leading the way to higher stakeholding, Investor Education and Protection Fund has significantly boosted stakeholding by an impressive 0.01 %.Observations show a significant difference of -0.04 % in Resident Individuals holding nominal share capital up to Rs. 2 lakhs’s financial performance between quarters.Leading the way to higher stakeholding, Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.23 %.Observations show a significant difference of -0.01 % in MADHUKER JAYANTILAL JHAVERI’s financial performance between quarters.Observations show a significant difference of -0.06 % in Non Resident Indians (NRIs)’s financial performance between quarters.Leading the way to higher stakeholding, Bodies Corporate has significantly boosted stakeholding by an impressive 0.06 %.Leading the way to higher stakeholding, Any Other (specify) has significantly boosted stakeholding by an impressive 0.11 %.Leading the way to higher stakeholding, Trusts has significantly boosted stakeholding by an impressive 0.01 %.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.1 %.
| Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
|---|---|---|---|---|---|
| Alternate Investment Funds | 0.007 | 0.007 | 0.44 | 0.45 | + 0.01 % |
The latest quarter saw a considerable enhancement in stakeholding for Alternate Investment Funds, reflecting an uptick of 0.01 % in their shares.
| Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
|---|---|---|---|---|---|
| Foreign Portfolio Investors Category I | 0.241 | 0.239 | 15.99 | 15.84 | -0.15 % |
| ATYANT CAPITAL INDIA FUND I | 0.050 | 0.050 | 3.35 | 3.34 | -0.01 % |
| VANDERBILT UNIVERSITY – ATYANT CAPITAL MANAGEMENT | 0.066 | 0.066 | 4.39 | 4.38 | -0.01 % |
| GOTHIC CORPORATION | 0.098 | 0.098 | 6.49 | 6.47 | -0.02 % |
| THE DUKE ENDOWMENT | 0.017 | 0.017 | 1.12 | 1.11 | -0.01 % |
| GOTHIC HSP CORPORATION | 0.021 | 0.021 | 1.42 | 1.41 | -0.01 % |
Stakeholding dwindled by -0.15 % for Foreign Portfolio Investors Category I in comparison to the preceding quarter.Stakeholding dwindled by -0.01 % for ATYANT CAPITAL INDIA FUND I in comparison to the preceding quarter.Stakeholding dwindled by -0.01 % for VANDERBILT UNIVERSITY – ATYANT CAPITAL MANAGEMENT in comparison to the preceding quarter.Stakeholding dwindled by -0.02 % for GOTHIC CORPORATION in comparison to the preceding quarter.Stakeholding dwindled by -0.01 % for THE DUKE ENDOWMENT in comparison to the preceding quarter.Stakeholding dwindled by -0.01 % for GOTHIC HSP CORPORATION in comparison to the preceding quarter.
-8
3-Year Profit
-3
5-Year Profit
2
10-Year Profit
1,508
Current Price
2,278
Market Cap
For the company identified by BSE code 532663, the financial performance highlights a solid five-year profit of -3 percents. This figure escalates to -8 percents over the three-year period, pointing to positive momentum in its earnings. Despite these encouraging trends, the trailing twelve-month (TTM) figures uncover an alarming profit loss of -33 percents. This decline, coupled with the fact that the company recorded zero sales across all periods examined, raises red flags about the sustainability of its business model and its ability to generate consistent revenue. Furthermore, the stock price fluctuations during this period further reflect the company's uncertain position. The stock started at 20 percents but has since plummeted to 9 percents recently, painting a picture of rapid decline. Over a longer ten-year horizon, the stock price stood at 19 percents, further underscoring the long-term challenges the company faces in maintaining investor confidence and market value.
The company has a market capitalization of ₹2,278 crore and is currently trading at ₹1,508 per share. Historically, the stock has fluctuated within a range of ₹1,955 / 1,011, reflecting both the opportunities and risks that investors perceive in the company. The P/E ratio, at 32.2, is relatively high, suggesting that the market has priced in substantial future growth or is willing to pay a premium for the company’s current earnings. The book value per share stands at ₹510, which reflects the net asset value of the company divided by the number of outstanding shares. The dividend yield is 1.66%, providing shareholders with a consistent return on their investment. ROCE is 12.0%, indicating how well the company is using its capital to generate profits, while ROE at 10.2% highlights the returns generated from shareholders' equity. The debt-to-equity ratio is 0.01, signaling low financial leverage, which is typically seen as a positive indicator of financial health. However, the company’s negative net cash flow of ₹26.4 crore might raise concerns about its cash generation capabilities or capital expenditures. With a Piotroski score of 3.00, the company's financial stability is evaluated on several factors. Finally, the Graham Number, at ₹736, provides an estimate of the stock’s intrinsic value, while the Price-to-Book (P/B) ratio of 2.96 highlights that the stock is trading at a premium to its book value, potentially reflecting positive market sentiment or overvaluation risks.
